{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:47:17Z","timestamp":1764240437440},"reference-count":28,"publisher":"The Society for Free Radical Research Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2021]]},"DOI":"10.3164\/jcbn.20-179","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T22:06:44Z","timestamp":1616623604000},"page":"216-221","source":"Crossref","is-referenced-by-count":6,"title":["Immunohistochemical differences in gastric mucosal damage between nodular and non-nodular gastritis caused by &lt;i&gt;Helicobacter pylori&lt;\/i&gt; infection"],"prefix":"10.3164","volume":"69","author":[{"given":"Kazuhisa","family":"Okamoto","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"},{"name":"Faculty of Welfare and Health Science, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Mizukami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadayoshi","family":"Okimoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanori","family":"Abe","sequence":"additional","affiliation":[{"name":"Abe Gastrointestinal Endoscopy Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Matsunari","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Hirashita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Oita University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between <i>Helicobacter pylori<\/i> seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169\u20131179.","DOI":"10.1016\/S0016-5085(98)70422-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Uemura N, Okamoto S, Yamamoto S, et al. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med 2001; 345: 784\u2013789.","DOI":"10.1056\/NEJMoa001999"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Herrero R, Park JY, Forman D. The fight against gastric cancer - the IARC Working Group report. Best Pract Res Clin Gastroenterol 2014; 28: 1107\u20131114.","DOI":"10.1016\/j.bpg.2014.10.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. <i>Helicobacter pylori<\/i> eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 2014; 348: g3174.","DOI":"10.1136\/bmj.g3174"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Take S, Mizuno M, Ishiki K, et al. Seventeen-year effects of eradicating <i>Helicobacter pylori<\/i> on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study. J Gastroenterol 2015; 50: 638\u2013644.","DOI":"10.1007\/s00535-014-1004-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of <i>Helicobacter pylori<\/i> on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392\u2013397.","DOI":"10.1016\/S0140-6736(08)61159-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Lee YC, Chiang TH, Chou CK, et al. Association between <i>Helicobacter pylori<\/i> eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 2016; 150: 1113\u20131124.e5.","DOI":"10.1053\/j.gastro.2016.01.028"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kikuchi S, Nakajima T, Kobayashi O, et al. Effect of age on the relationship between gastric cancer and <i>Helicobacter pylori<\/i>. Tokyo Research Group of Prevention for Gastric Cancer. Jpn J Cancer Res 2000; 91: 774\u2013779.","DOI":"10.1111\/j.1349-7006.2000.tb01012.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Eastham EJ, Elliott TS, Berkeley D, Jones DM. <i>Campylobacter pylori<\/i> infection in children. J Infect 1988; 16: 77\u201379.","DOI":"10.1016\/S0163-4453(88)96205-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Miyamoto M, Haruma K, Yoshihara M, et al. Nodular gastritis in adults is caused by <i>Helicobacter pylori<\/i> infection. Dig Dis Sci 2003; 48: 968\u2013975.","DOI":"10.1023\/A:1023016000096"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kamada T, Tanaka AKI, Yamanaka Y, et al. Nodular gastritis with <i>Helicobacter pylori <\/i>infection is strongly associated with diffuse-type gastric cancer in young patients. Dig Endosc 2007; 19: 180\u2013184.","DOI":"10.1111\/j.1443-1661.2007.00750.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kamada T, Hata J, Tanaka A, et al. Nodular gastritis and gastric cancer. Dig Endosc 2006; 18: 79\u201383.","DOI":"10.1111\/j.1443-1661.2006.00588.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kimura K. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 13: 87\u201397.","DOI":"10.1055\/s-0028-1098086"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161\u20131181.","DOI":"10.1097\/00000478-199610000-00001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Nakajima N, Kozu K, Kobayashi S. The expression of IGF-1R in <i>Helicobacter pylori<\/i>-infected intestinal metaplasia and gastric cancer. J Clin Biochem Nutr 2016; 59: 53\u201357.","DOI":"10.3164\/jcbn.16-11"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Yamaoka Y, Kudo T, Lu H, Casola A, Brasier AR, Graham DY. Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in <i>Helicobacter pylori<\/i> infection. Gastroenterology 2004; 126: 1030\u20131043.","DOI":"10.1053\/j.gastro.2003.12.048"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Shimoyama T, Fukuda S, Liu Q, Nakaji S, Fukuda Y, Sugawara K. <i>Helicobacter pylori<\/i> water soluble surface proteins prime human neutrophils for enhanced production of reactive oxygen species and stimulate chemokine production. J Clin Pathol 2003; 56: 348\u2013351.","DOI":"10.1136\/jcp.56.5.348"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Lee KE, Khoi PN, Xia Y, et al. <i>Helicobacter pylori<\/i> and interleukin-8 in gastric cancer. World J Gastroenterol 2013; 19: 8192\u20138202.","DOI":"10.3748\/wjg.v19.i45.8192"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Levine AJ, Finlay CA, Hinds PW. P53 is a tumor suppressor gene. Cell 2004; 116 (2 Suppl): S67\u2013S69.","DOI":"10.1016\/S0092-8674(04)00036-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49\u201353.","DOI":"10.1126\/science.1905840"},{"key":"21","unstructured":"21 Hinds PW, Finlay CA, Quartin RS, et al. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the \u201chot spot\u201d mutant phenotypes. Cell Growth Differ 1990; 1: 571\u2013580."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Satoh K, Kihira K, Kawata H, et al. p53 expression in the gastric mucosa before and after eradication of <i>Helicobacter pylori<\/i>. Helicobacter 2001; 6: 31\u201336.","DOI":"10.1046\/j.1523-5378.2001.00003.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kodama M, Fujioka T, Murakami K, et al. Eradication of <i>Helicobacter pylori<\/i> reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol 2005; 20: 941\u2013946.","DOI":"10.1111\/j.1440-1746.2005.03880.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kodama M, Murakami K, Okimoto T, Sato R, Watanabe K, Fujioka T. Expression of mutant type-p53 products in <i>H pylori<\/i>-associated chronic gastritis. World J Gastroenterol 2007; 13: 1541\u20131546.","DOI":"10.3748\/wjg.v13.i10.1541"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Murakami K, Mitomi H, Yamashita K, Tanabe S, Saigenji K, Okayasu I. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1\/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol 2001; 115: 224\u2013234.","DOI":"10.1309\/VLF5-UCNH-XQM2-X410"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Shenoy S. CDH1 (E-cadherin) mutation and gastric cancer: genetics, molecular mechanisms and guidelines for management. Cancer Manag Res 2019; 11: 10477\u201310486.","DOI":"10.2147\/CMAR.S208818"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402\u2013405.","DOI":"10.1038\/32918"},{"key":"28","unstructured":"28 Zullo A, Romiti A, Borrini F, et al. Alteration of E-cadherin expression in gastric mucosa: role of intestinal metaplasia and <i>Helicobacter pylori<\/i> infection. Anticancer Res 2004; 24: 1603\u20131607."}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/69\/2\/69_20-179\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:38:59Z","timestamp":1715143139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/69\/2\/69_20-179\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.20-179","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"20-179"}}